Effects of Vitamin D3 and Prebiotics Supplementation on Cardiovascular Risk Factors in Patients With Type 2 Diabetes - Trial NCT06351566
Access comprehensive clinical trial information for NCT06351566 through Pure Global AI's free database. This phase not specified trial is sponsored by Huazhong University of Science and Technology and is currently Not yet recruiting. The study focuses on Diabetes Mellitus, Type 2. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Huazhong University of Science and Technology
Timeline & Enrollment
N/A
Apr 24, 2024
Dec 31, 2025
Primary Outcome
Glycated hemoglobin (HbA1c),Concentration of blood lipids,Metagenomic analysis of the gut microbiota
Summary
The goal of this randomized, double-blind, placebo-controlled, 6-month supplementation study
 in individuals with type 2 diabetes is to investigate whether taking daily dietary
 supplements of vitamin D3 (1600 IU) or prebiotics (inulin, 10 gram) has beneficial effects on
 cardiovascular disease risk factors.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06351566
Non-Device Trial